SPL RF Jan 2021

EN_01459393_0334

30,00 EUR Private use
Making print for private purpose, storage in computer memory, no distribution rights.
40,00 EUR Internet - private use
Strictly for editorial, single use on a personal (nonprofit) web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
75,00 EUR Internet commercial use
Strictly for editorial, single use on a commercial web site, Internet portal, social media (Facebook, Instagram etc.), blog for 1 year. Not for resale. Maximum picture size 2000px.
90,00 EUR Print use
Strictly for editorial, single use, inside of newspaper, magazine, book (including digital version), one edition, one single country. Not for resale.

Gross prices

special instructions

SPECIAL RATES FOR EDITORIAL AND BOOKS RF RATES FOR OTHER USE - INTERNET +100% Internet +100%

caption

Covid-19 RNA vaccine, illustration. The vaccine consists of strands of mRNA (messenger ribonucleic acid) encased in a lipid nanoparticle sphere. The mRNA codes for a mutated version of the viral spike protein found on the surface of the SARS-CoV-2 coronavirus that causes Covid-19. When injected into the body the mRNA is taken up by the body's cells, which manufacture copies of the protein. The proteins stimulate an immune response, causing the body to produce antibodies against the spike protein. This means that the body is primed to attack the virus should it be encountered after vaccination, preventing disease. The first RNA vaccine approved for human use, developed against the SARS-CoV-2 coronavirus by Pfizer/BioNTech, was approved in the UK on 2nd December 2020.

headline SPL RF Jan 2021

created date 2021-01-02

credit JUAN GAERTNER/Science Photo Library RF/East News

source Science Photo Library RF

byline JUAN GAERTNER

original transmission reference f0325905

weight 6,01MB

size 68cm x 51cm by 300dpi

keywords - Show

1ST, ACID, ANTIBODIES, ANTIBODY, ANTIGEN, ARTWORK, BACKGROUND, BIOLOGICAL, BIOLOGY, BIONTECH, BIOTECHNOLOGICAL, BIOTECHNOLOGY, BLACK, CONCEPTS, CONCEPTUAL, CONDITION, CORONAVIRUS, COVID-19, DISEASE, DISORDER, EPIDEMIC, FIRST, GAERTNER, HCOV, ILLUSTRATION, IMMUNISATION, IMMUNOGLOBULIN, JUAN, MESSENGER, MRNA, NO-ONE, NOBODY, PANDEMIC, PARTICLE, PFIZER, PROTEIN, RIBONUCLEIC, RNA, SARS-COV, SARS-COV-2, VACCINATION, VACCINE, VIRAL, VIRION, VIRUS,